Schütte, Hartwig <br/><br/>
Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.  [electronic resource] 

 -  Transplantation  Mar 2003 
 - 814-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/01.TP.0000053751.22207.4E  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Capillary Permeability--drug effects<br/>Cyclic AMP--metabolism<br/>Disease Models, Animal<br/>Drug Synergism<br/>Epoprostenol--pharmacology<br/>Female<br/>Lung Transplantation<br/>Male<br/>Microcirculation--drug effects<br/>Nebulizers and Vaporizers<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Pulmonary Circulation--drug effects<br/>Pulmonary Wedge Pressure--drug effects<br/>Rabbits<br/>Reperfusion Injury--drug therapy<br/>Rolipram--pharmacology<br/>Weight Gain--drug effects